Science & Technology: Pharmacogenomics and Pharmaceutical Development: Current Thinking and Regulatory Guidance

| 01 March 2008

Will pharmacogenomics truly become part of a much larger paradigm of personalized medicine, predicting the best possible treatment option in a regulatory framework designed to pick up adverse reactions much earlier in the pharmaceutical lifecycle?

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy